期刊文献+

Farnesoid X receptor,the bile acid sensing nuclear receptor,in liver regeneration 被引量:20

Farnesoid X receptor,the bile acid sensing nuclear receptor,in liver regeneration
原文传递
导出
摘要 The liver is unique in regenerative potential, which could recover the lost mass and function after injury from ischemia and resection. The underlying molecular mechanisms of liver regeneration have been extensively studied in the past using the partial hepatectomy(PH) model in rodents, where 2/3 PH is carried out by removing two lobes. The whole process of liver regeneration is complicated, orchestrated event involving a network of connected interactions, which still remain fully elusive. Bile acids(BAs) are ligands of farnesoid X receptor(FXR), a nuclear receptor of ligand-activated transcription factor. FXR has been shown to be highly involved in liver regeneration. BAs and FXR not only interact with each other but also regulate various downstream targets independently during liver regeneration. Moreover, recent findings suggest that tissue-specific FXR also contributes to liver regeneration significantly. These novel findings suggest that FXR has much broader role than regulating BA, cholesterol, lipid and glucose metabolism. Therefore, these researches highlight FXR as an important pharmaceutical target for potentialuse of FXR ligands to regulate liver regeneration in clinic. This review focuses on the roles of BAs and FXR in liver regeneration and the current underlying molecular mechanisms which contribute to liver regeneration. The liver is unique in regenerative potential, which could recover the lost mass and function after injury from ischemia and resection. The underlying molecular mechanisms of liver regeneration have been extensively studied in the past using the partial hepatectomy (PH) model in rodents, where 2/3 PH is carried out by removing two lobes. The whole process of liver regeneration is complicated, orchestrated event involving a network of connected interactions, which still remain fully elusive. Bile acids (BAs) are ligands of farnesoid X receptor (FXR), a nuclear receptor of hgand-activated transcription factor. FXR has been shown to be highly involved in liver regeneration. BAs and FXR not only interact with each other hut also regulate various downstream targets independently during liver regeneration. Moreover, recent findings suggest that tissue-specific FXR also contributes to liver regeneration significantly. These novel findings suggest that FAR has much broader role than regulating BA, cholesterol, lipid and glucose metabolism. Therefore, these researches highlight FXR as an important pharmaceutical target for potential use of FXR ligands to regulate liver regeneration in clinic. This review focuses on the roles of BAs and FXR in liver regeneration and the current underlying molecular mechanisms which contribute to liver regeneration. (C) 2015 Chinese Pharmaceutical Association and institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. All rights reserved.
出处 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2015年第2期93-98,共6页 药学学报(英文版)
基金 supported by the National Institutes of Health Fund (Nos.DK081343,DK090036 and GM104037 to Grace L.Guo) the National Natural Science Foundation of China (No.81302059) the Natural Science Foundation of Heilongjiang Province of China (No.LC2013C35) the Foundation of Educational Committee of Heilongjiang Province of China (No.12541300) supported by the Scientific Research Foundation for the Returned Overseas Chinese Scholars,State Education Ministry and Science Foundation for The Excellent Youth Scholars of the Fourth Hospital of Harbin Medical University in China
关键词 Farnesoid X receptor Liver regeneration Bile acids Fibroblast growth factor 15 Liver-intestine croass talk Transmembrane G protein coupled receptor 5 Farnesoid X receptor Liver regeneration Bile acids Fibroblast growth factor 15 Liver-intestine croass talk Transmembrane G protein coupled receptor 5
  • 相关文献

参考文献2

二级参考文献27

  • 1Thomas Pusi,Ulrich Beuers.Ursodeoxycholic acid treatment of vanishing bile duct syndromes[J].World Journal of Gastroenterology,2006,12(22):3487-3495. 被引量:18
  • 2Daisuke Komichi,Susumu Tazuma,Tomoji Nishioka,Hideyuki Hyogo,Mizuho Une,Kazuaki Chayama.Unique Inhibition of Bile Salt-Induced Apoptosis by Lecithins and Cytoprotective Bile Salts in Immortalized Mouse Cholangiocytes[J].Digestive Diseases and Sciences.2003(12)
  • 3Seon-Hee Oh,Ki-Jung Yun,Ji-Xing Nan,Dong-Hwan Sohn,Byung-Hoon Lee.Changes in expression and immunolocalization of protein associated with toxic bile salts-induced apoptosis in rat hepatocytes[J].Archives of Toxicology.2003(2)
  • 4Predrag Ljubuncic,Zahava Tanne,Arieh Bomzon.Ursodeoxycholic Acid Suppresses Extent of Lipid Peroxidation in Diseased Liver in Experimental Cholestatic Liver Disease[J].Digestive Diseases and Sciences.2000(10)
  • 5Ermenegildo E. Frezza,Giorgio E. Gerunda,Mario Plebani,Alessandra Galligioni,Alda Giacomini,Daniele Neri,Alvise Maffei Faccioli,Dr. Claudio Tiribelli.Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat[J].Digestive Diseases and Sciences.1993(7)
  • 6Calmus Y,Guechot J,Podevin P,Bonnef is MT,Giboudeau J,Poupon R.Differential effects of chenodeoxycholic and ursodeoxycholic acids on interleukin 1, interleukin 6 and tumor necrosis factor-alpha production by monocytes[].Hepatology.1992
  • 7Yoshikawa M,Matsui Y,Kawamoto H,Toyohara M,Matsumura K,Yamao J,Kuriyama S,Fukui H,Ishizaka S.Intragastric administration of ursodeoxycholic acid suppresses immunoglobulin secretion by lymphocytes from liver, but not from peripheral blood, spleen or Peyer‘s patches in mice[].International Journal of Immunopharmacology.1998
  • 8Tanaka H,Makino Y,Miura T,Hirano F,Okamoto K,Komura K,Sato Y,Makino I.Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway[].J Immunol.1996
  • 9Oftebro H,Bjorkhem I,Strmer FC,Pedersen JI.Cerebrotendinous xanthomatosis: defective liver mitochondrial hydroxylation of chenodeoxycholic acid precursors[].Journal of Lipid Research.1981
  • 10Thomas C,Pellicciari R,Pruzanski M,Auwerx J,Schoonjans K.Targeting bile-acid signalling for metabolic diseases[].Nature Reviews Drug Discovery.2008

共引文献59

同被引文献122

引证文献20

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部